Tags

Type your tag names separated by a space and hit enter

Comparative validation of amisulpride determination in pharmaceuticals by several chromatographic, electrophoretic and spectrophotometric methods.
Anal Chim Acta. 2007 May 08; 590(2):195-202.AC

Abstract

Nine accurate methods for determination of amisulpride in tablets: reversed phase high pressure liquid chromatography (RP-HPLC), aqueous capillary electrophoresis (CE), non-aqueous CE, normal phase (NP) and reversed-phase (RP) high performance thin layer chromatography (HPTLC) with densitometry and videodensitometry, and direct and derivative UV spectrophotometry were developed and validated. The HPLC was carried out using Nova-Pak C8 column and mobile phase consisted of acetonitrile-methanol-phosphate buffer pH 4.50 (15:5:80, v/v/v) with flow rate 1 mL min(-1) and UV detection at 225 nm. The moclobemide was used as the internal standard. CE was performed using 75 microm x 82 cm fused silica capillary (65 cm effective), the internal standard was quetiapine. Detection was carried out at 225 nm. For aqueous analysis, the 30 mM phosphate buffer pH 6.00, 30 kV voltage and 30 degrees C temperature were chosen, non-aqueous determination was performed with ammonia acetate 1 mM in acetonitrile-methanol (1:1, v/v), 30 kV voltage and 25 degrees C temperature. NP-HPTLC was carried out using HPTLC silica F254 plates, developed with hexane-ethanol-propylamine (5:5:0.1, v/v/v) through 9 cm distance. RP-HPTLC was developed with HPTLC RP8F254 plates, with mobile phase of tetrahydrofuran-phosphate buffer pH 3.50 (4:6, v/v), distance 4.5 cm. Both analyses were performed in horizontal chambers and scanned with densitometer at 275 nm or videodensitometer at 254 nm. UV spectrophotometry was carried out in methanol, using 224 nm for direct assay and 258 nm (D1) for derivative assay. The precision and accuracy of all the methods were complexively compared. The highest accuracy was observed in RP-HPTLC, the highest precision was achieved in non-aqueous CE method. The differences were not significant, so all the elaborated methods can be used in routine analysis.

Authors+Show Affiliations

Department of Medicinal Chemistry, Skubiszewski Medical University, Jaczewskiego 4, 20-090 Lublin, Poland. robert.skibinski@am.lublin.plNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

17448345

Citation

Skibiński, Robert, et al. "Comparative Validation of Amisulpride Determination in Pharmaceuticals By Several Chromatographic, Electrophoretic and Spectrophotometric Methods." Analytica Chimica Acta, vol. 590, no. 2, 2007, pp. 195-202.
Skibiński R, Komsta Ł, Hopkała H, et al. Comparative validation of amisulpride determination in pharmaceuticals by several chromatographic, electrophoretic and spectrophotometric methods. Anal Chim Acta. 2007;590(2):195-202.
Skibiński, R., Komsta, Ł., Hopkała, H., & Suchodolska, I. (2007). Comparative validation of amisulpride determination in pharmaceuticals by several chromatographic, electrophoretic and spectrophotometric methods. Analytica Chimica Acta, 590(2), 195-202.
Skibiński R, et al. Comparative Validation of Amisulpride Determination in Pharmaceuticals By Several Chromatographic, Electrophoretic and Spectrophotometric Methods. Anal Chim Acta. 2007 May 8;590(2):195-202. PubMed PMID: 17448345.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparative validation of amisulpride determination in pharmaceuticals by several chromatographic, electrophoretic and spectrophotometric methods. AU - Skibiński,Robert, AU - Komsta,Łukasz, AU - Hopkała,Hanna, AU - Suchodolska,Izabela, Y1 - 2007/03/24/ PY - 2006/11/10/received PY - 2007/03/15/revised PY - 2007/03/19/accepted PY - 2007/4/24/pubmed PY - 2007/5/12/medline PY - 2007/4/24/entrez SP - 195 EP - 202 JF - Analytica chimica acta JO - Anal Chim Acta VL - 590 IS - 2 N2 - Nine accurate methods for determination of amisulpride in tablets: reversed phase high pressure liquid chromatography (RP-HPLC), aqueous capillary electrophoresis (CE), non-aqueous CE, normal phase (NP) and reversed-phase (RP) high performance thin layer chromatography (HPTLC) with densitometry and videodensitometry, and direct and derivative UV spectrophotometry were developed and validated. The HPLC was carried out using Nova-Pak C8 column and mobile phase consisted of acetonitrile-methanol-phosphate buffer pH 4.50 (15:5:80, v/v/v) with flow rate 1 mL min(-1) and UV detection at 225 nm. The moclobemide was used as the internal standard. CE was performed using 75 microm x 82 cm fused silica capillary (65 cm effective), the internal standard was quetiapine. Detection was carried out at 225 nm. For aqueous analysis, the 30 mM phosphate buffer pH 6.00, 30 kV voltage and 30 degrees C temperature were chosen, non-aqueous determination was performed with ammonia acetate 1 mM in acetonitrile-methanol (1:1, v/v), 30 kV voltage and 25 degrees C temperature. NP-HPTLC was carried out using HPTLC silica F254 plates, developed with hexane-ethanol-propylamine (5:5:0.1, v/v/v) through 9 cm distance. RP-HPTLC was developed with HPTLC RP8F254 plates, with mobile phase of tetrahydrofuran-phosphate buffer pH 3.50 (4:6, v/v), distance 4.5 cm. Both analyses were performed in horizontal chambers and scanned with densitometer at 275 nm or videodensitometer at 254 nm. UV spectrophotometry was carried out in methanol, using 224 nm for direct assay and 258 nm (D1) for derivative assay. The precision and accuracy of all the methods were complexively compared. The highest accuracy was observed in RP-HPTLC, the highest precision was achieved in non-aqueous CE method. The differences were not significant, so all the elaborated methods can be used in routine analysis. SN - 1873-4324 UR - https://www.unboundmedicine.com/medline/citation/17448345/Comparative_validation_of_amisulpride_determination_in_pharmaceuticals_by_several_chromatographic_electrophoretic_and_spectrophotometric_methods_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0003-2670(07)00589-2 DB - PRIME DP - Unbound Medicine ER -